Peroxisome proliferator-activated receptor-γ: From adipogenesis to carcinogenesis

Journal of Molecular Endocrinology

Volumn 27, Issue 1, 2001, Pages 1-9

  Fajas, L ^a   Debril, M B ^a   Auwerx, J ^a  

^a Department of Biology and Structural Genomics   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; DNA; ESTROGEN RECEPTOR; FATTY ACID; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P130; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; APOPTOSIS; BREAST CANCER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; COLON TUMOR; CONTROLLED STUDY; DNA SYNTHESIS; FATTY ACID METABOLISM; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0034892766     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0270001     Document Type: Review

References (105)

1. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site
2. PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
3. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
4. Leptin
5. Association of the Pro12 Ala variant in peroxisome proliferator-activated receptor gamma2 gene with obesity in two Caucasian populations
6. Cachectin (tumor necrosis factor): A macrophage hormone governing cellular metabolism and inflammatory response
7. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells
8. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase
9. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer
10. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs
11. Activation of peroxisome proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages
12. CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator activated receptor γ2 promoter
13. Opposing roles of pRB and p107 in adipocyte differentiation
14. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
15. A Pro 12 Ala substitution in the human peroxisome proliferator-activated receptor gamma2 is associated with decreased receptor activity, improved insulin sensitivity and lowered body mass index
16. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma
17. Thiazolidinediones repress ob gene expression via activation of PPARγ
18. Ligands for peroxisome proliferator-activated receptor-γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
19. Transcriptional control of adipogenesis
20. Regulation of PPARγ expression by ADD-1/SREBP-1: Implications for adipocyte differentiation and metabolism
21. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene
22. Dietary factors and risk of colon cancer
23. Identification and characterization of the familial adenomatous polyposis coli gene
24. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death
25. The Pro12 Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes
26. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
27. The mouse obese gene. Genomic organization, promoter activity and activation by CCAAT/enhancer-binding protein alpha
28. Regulation of cell proliferation by the E2F transcription factors
29. The block of adipocyte differentiation by a C-terminally truncated, but not by full-length, simian virus 40 large tumor antigen is dependent on an intact retinoblastoma susceptibility protein family binding domain
30. Decreased expression of murine PPARγ in adipose tissue during endotoxinemia
31. Down-regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer
32. Altered gene expression for tumor necrosis factor-α and its receptor during drug and dietary modulation of insulin resistance
33. Functional antagonism between CCAAT/enhancer binding protein-α and peroxisome proliferator-activated receptor-γ on the leptin promoter
34. Adipose tissue expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
35. Tumor necrosis factor α inhibits signaling from the insulin receptor
36. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
37. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance
38. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα
39. Inhibition of adipogenesis through MAP-kinase mediated phosphorylation of PPARγ
40. Chemoprevention of spontaneous intestinal adenoma in the ApcMin mouse model by the nonsteroidal anti-inflammatory drug piroxicam
41. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes
42. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism
43. Lessons from hereditary colorectal cancer
44. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells
45. PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma
46. Ligand for peroxisome proliferator activated receptor γ (troglitazone) has potent anti-tumor effects against human prostate cancer both in vitro and in vivo
47. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
48. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
49. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice
50. The nuclear receptor superfamily: The second decade
51. Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa
52. Coordinate regulation of the expression of the fatty acid transport protein (FATP) and acyl CoA synthetase genes by PPARα and PPARγ activators
53. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency
54. The adipocyte specific transcription factor, C/EBPα modulates human ob gene expression
55. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
56. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis
57. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27 KiP1 in human pancreatic carcinoma cells
58. Terminal differentiation of human breast cancer through PPARγ
59. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer
60. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
61. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients
62. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats
63. Suppression of intestinal polyposis in APCΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
64. Mitotic clonal expansion during preadipocyte differentiation: Calpain-mediated turnover of p27
65. Thiazolidinediones block tumor necrosis factor-α-induced inhibition of insulin signalling
66. Molecular diagnosis of familial adenomatous polyposis
67. Analysis of cell cycle arrest in adipocyte differentiation
68. Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation
69. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
70. Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP)
71. PPARgamma is required for the differentiation of adipose tissue in vivo and in vitro
72. Inhibition of adipogenesis by Wnt signaling
73. Activators of the nuclear receptor PPARγ enhance colon polyp formation
74. Differential regulation of peroxisome proliferator activated receptor γ1 (PPARγ1) and PPARγ2 mRNA expression in early stages of adipogenesis
75. E2Fs and the retinoblastoma protein family
76. Differentiation and reversal of malignant changes in colon cancer through PPARγ
77. Loss-of-function mutations in PPARgamma associated with human colon cancer
78. Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists
79. Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation
80. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter
81. PPARα and PPARγ activators direct a tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
82. BRL 49653 blocks lipolytic actions of tumor necrosis factor-alpha: A potential new insulin-sensitizing mechanism for thiazolidinediones
83. Adipogenesis and obesity: Rounding out the big picture
84. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
85. Tamoxifen resistant breast cancer: Coregulators determine the direction of transcription by antagonist-occupied steroid receptors
86. Aspirin use and reduced risk of fatal colon cancer
87. Function of GATA transcription factors in preadipocyte-adipocyte transition
88. ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation
89. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer
90. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
91. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene
92. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor
93. A macrophage factor inhibits adipocyte gene expression; an in vitro model for cachexia
94. Human peroxisome proliferator-activated receptor gamma 2: Genetic mapping, identification of a variant in the coding sequence and exclusion as the gene responsible for lipoatrophic diabetes
95. Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1→S transition in vascular smooth muscle cells
96. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice
97. CCAAT/enhancer binding protein expression is rapidly extinguished in TA1 adipocyte cells treated with tumor necrosis factor
98. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis
99. Induction of peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ and glucocorticoids
100. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity
101. TNFα-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARγ without effects on Pref-1 expression
102. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins
103. Molecular scanning of the human peroxisome proliferator activated receptor gamma gene in diabetic Caucasians: Identification of a Pro12 Ala PPARgamma 2 missense mutation
104. Down-regulation of the expression of the obese gene by antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice
105. Structural organization of mouse peroxisome proliferator activated receptor γ (mPPARγ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms